Influence of socio-economic status on functional recovery after ARDS caused by SARS-CoV-2: the multicentre, observational RECOVIDS study

被引:3
|
作者
Declercq, Pierre-Louis [1 ]
Fournel, Isabelle [2 ,3 ]
Demeyere, Matthieu [4 ]
Berraies, Anissa [5 ]
Ksiazek, Elea [2 ,3 ]
Nyunga, Martine [6 ]
Daubin, Cedric [7 ]
Ampere, Alexandre [8 ]
Sauneuf, Bertrand [9 ]
Badie, Julio [10 ]
Delbove, Agathe [11 ]
Nseir, Saad [12 ,13 ]
Artaud-Macari, Elise [14 ]
Bironneau, Vanessa [15 ,16 ]
Ramakers, Michel [17 ]
Maizel, Julien [18 ]
Miailhe, Arnaud-Felix [19 ]
Lacombe, Beatrice [20 ]
Delberghe, Nicolas [21 ]
Oulehri, Walid [22 ]
Georges, Hugues [23 ]
Tchenio, Xavier [24 ]
Clarot, Caroline [25 ]
Redureau, Elise [26 ]
Bourdin, Gael [27 ]
Federici, Laura [28 ]
Adda, Melanie [29 ]
Schnell, David [30 ]
Bousta, Mehdi [31 ]
Salmon-Gandonniere, Charlotte [32 ]
Vanderlinden, Thierry [33 ]
Plantefeve, Gaetan [34 ]
Delacour, David [35 ]
Delpierre, Cyrille [36 ]
Le Bouar, Gurvan [37 ]
Sedillot, Nicholas
Beduneau, Gaetan [38 ]
Riviere, Antoine [39 ]
Meunier-Beillard, Nicolas [2 ]
Gelinotte, Stephanie [1 ]
Rigaud, Jean-Philippe [1 ,40 ]
Labruyere, Marie [41 ,42 ,43 ,44 ]
Georges, Marjolaine [45 ,46 ]
Binquet, Christine [2 ,3 ]
Quenot, Jean-Pierre [41 ,42 ,43 ,44 ]
机构
[1] CH Dieppe, Serv Med Intens Reanimat, Dieppe, France
[2] CHU Dijon, Ctr Invest Clin, Dijon, France
[3] INSERM, CIC 1432, Module Epidemiol Clin, Dijon, France
[4] CHU Rouen, Serv Radiol, F-76000 Rouen, France
[5] CH Chartres, Serv Pneumol, Chartres, France
[6] CH Roubaix, Serv Med Intens Reanimat, Roubaix, France
[7] CHU Caen Normandie, Dept Med Intens Care, Caen, France
[8] CH Bethune, Serv Pneumol, Bethune, France
[9] CH Publ Cotentin, Serv Med Intens Reanimat, Cherbourg En Cotentin, France
[10] Hop Nord Franche Comte, Serv Med Intens Reanimat, Trevenans, France
[11] CHBA Vannes, Serv Reanimat Polyvalente, Vannes, France
[12] CHRU Roger Salengro, Serv Med Intens Reanimat, Lille, France
[13] Univ Lille, UGSF Unite Glycobiol Struct & Fonct, CNRS, Inserm U1285,UMR 8576, Lille, France
[14] Univ Normandie, Dept Pneumol, Thorac Oncol & Resp Intens Care Unit, UNIROUEN,EA3830,CHU Rouen, Rouen, France
[15] CHU Poitiers, Serv Pneumol, Poitiers, France
[16] Univ Poitiers, INSERM CIC 1402, ALIVES Res Grp, Poitiers, France
[17] Ctr Hosp Mem St Lo, Serv Med Intens Reanimat, St Lo, France
[18] CHU Amiens, Serv Med Intens Reanimat, Amiens, France
[19] CHU Nantes, Serv Med Intens Reanimat, Nantes, France
[20] Grp Hosp Bretagne Sud, Serv Reanimat Polyvalente, Lorient, France
[21] CHES Evreux, Serv Pneumol, Evreux, France
[22] CHRU Strasbourg, Serv Reanimat Chirurgicale, Strasbourg, France
[23] CH Tourcoing, Serv Med Intens Reanimat, Tourcoing, France
[24] Ctr Hosp Fleyriat, Serv Reanimat Polyvalente, Bourg En Bresse, France
[25] CH Abbeville, Serv Pneumol, Abbeville, France
[26] CHD Vendee, Serv Pneumol, La Roche Sur Yon, France
[27] CH St Joseph St Luc, Serv Reanimat Polyvalente, Lyon, France
[28] Hop Louis Mourier, AP HP, Serv Med Intens Reanimat, Colombes, France
[29] Hop Nord Marseille, Hop Marseille, Serv Med Intens Reanimat, Marseille, France
[30] CH Angouleme, Serv Reanimat Polyvalente & USC, Angouleme, France
[31] Grp Hosp Havre, Serv Reanimat Med Chirug, Le Havre, France
[32] CHRU Tours, Serv Med Intens Reanimat, Tours, France
[33] Lille Catholic Univ, St Philibert Hosp, Intens Care Unit, ETHICS EA 7446, Lille, France
[34] CH Argenteuil, Serv Med Intens Reanimat, Argenteuil, France
[35] Clin Cedre, Serv Radiol, Bois Guillaume, France
[36] Univ Toulouse, CERPOP, Inserm, Toulouse, France
[37] CHES Evreux, Serv Med Intens Reanimat, Evreux, France
[38] Normandie Univ, Dept Med Intens Care, UNIROUEN, UR3830,CHU Rouen, F-76000 Rouen, France
[39] CH Abbeville, Serv Reanimat Polyvalente, Abbeville, France
[40] CHU Caen, Espace Reflex Eth Normandie, Caen, France
[41] Burgundy Univ Hosp, Dept Intens Care, 14 Rue Paul Gaffarel,BP 77908, F-21079 Dijon, France
[42] Univ Burgundy, INSERM Res Ctr LNC, Lipness Team, UMR1231, Dijon, France
[43] Univ Burgundy, LabEx LipSTIC, Dijon, France
[44] Univ Burgundy, INSERM CIC 1432, Clin Epidemiol, Dijon, France
[45] Univ Hosp, Dept Pulm Med, Dijon, France
[46] Univ Hosp, Intens Care Unit, Dijon, France
关键词
ARDS; COVID-19; Socio-economic; Deprivation; Respiratory sequelae; THORACIC SOCIETY; LUNG-FUNCTION; COVID-19; HEALTH; DEPRIVATION; SPIROMETRY; INDEX; RISK;
D O I
10.1007/s00134-023-07180-y
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose: Survivors after acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19) are at high risk of developing respiratory sequelae and functional impairment. The healthcare crisis caused by the pandemic hit socially disadvantaged populations. We aimed to evaluate the influence of socio-economic status on respiratory sequelae after COVID-19 ARDS. Methods: We carried out a prospective multicenter study in 30 French intensive care units (ICUs), where ARDS survivors were pre-enrolled if they fulfilled the Berlin ARDS criteria. For patients receiving high flow oxygen therapy, a flow >= 50 l/min and an FiO(2) >= 50% were required for enrollment. Socio- economic deprivation was defined by an EPICES (Evaluation de la Precarite et des Inegalites de sante dans les Centres d'Examens de Sante - Evaluation of Deprivation and Inequalities in Health Examination Centres) score >= 30.17 and patients were included if they performed the 6-month evaluation. The primary outcome was respiratory sequelae 6 months after ICU discharge, defined by at least one of the following criteria: forced vital capacity < 80% of theoretical value, diffusing capacity of the lung for carbon monoxide < 80% of theoretical value, oxygen desaturation during a 6-min walk test and fibrotic-like findings on chest computed tomography. Results: Among 401 analyzable patients, 160 (40%) were socio- economically deprived and 241 (60%) non-deprived; 319 (80%) patients had respiratory sequelae 6 months after ICU discharge (81% vs 78%, deprived vs non-deprived, respectively). No significant effect of socio-economic status was identified on lung sequelae (odds ratio (OR), 1.19 [95% confidence interval (CI), 0.72-1.97]), even after adjustment for age, sex, most invasive respiratory support, obesity, most severe P/F ratio (adjusted OR, 1.02 [95% CI 0.57-1.83]). Conclusions: In COVID-19 ARDS survivors, socio-economic status had no significant influence on respiratory sequelae 6 months after ICU discharge.
引用
收藏
页码:1168 / 1180
页数:13
相关论文
共 50 条
  • [41] A prospective observational study on the effect of intravenous immunoglobulin on small fiber neuropathy after SARS-CoV-2 infection or vaccination
    Shin, J.
    Lee, J.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [42] Risk of SARS-CoV-2 Reinfection 18 Months After Primary Infection: Population-Level Observational Study
    Flacco, Maria Elena
    Soldato, Graziella
    Martellucci, Cecilia Acuti
    Di Martino, Giuseppe
    Carota, Roberto
    Caponetti, Antonio
    Manzoli, Lamberto
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [43] Risk of SARS-CoV-2 Reinfection 3 Years after the Start of the Pandemic: A Population-Level Observational Study
    Martellucci, Cecilia Acuti
    Flacco, Maria Elena
    Soldato, Graziella
    Di Martino, Giuseppe
    Carota, Roberto
    Rosso, Annalisa
    De Benedictis, Marco
    Di Marco, Graziano
    Di Luzio, Rossano
    Lisbona, Francesco
    Caponetti, Antonio
    Manzoli, Lamberto
    LIFE-BASEL, 2023, 13 (11):
  • [44] Clinical, radiological and functional outcomes in patients with SARS-CoV-2 pneumonia: a prospective observational study (vol 21, 136, 2021)
    Gianella, Pietro
    Rigamonti, Elia
    Marando, Marco
    Tamburello, Adriana
    Gauthier, Lorenzo Grazioli
    Argentieri, Gianluca
    Puligheddu, Carla
    Pagnamenta, Alberto
    Pons, Marco
    Fusi-Schmidhauser, Tanja
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [45] Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: A controlled cohort study
    Noviello, Daniele
    Costantino, Andrea
    Muscatello, Antonio
    Bandera, Alessandra
    Consonni, Dario
    Vecchi, Maurizio
    Basilisco, Guido
    NEUROGASTROENTEROLOGY AND MOTILITY, 2022, 34 (02):
  • [46] FUNCTIONAL GASTROINTESTINAL AND SOMATOFORM SYMPTOMS FIVE MONTHS AFTER SARS-COV-2 INFECTION: A CONTROLLED COHORT STUDY
    Noviello, D.
    Costantino, A.
    Muscatello, A.
    Bandera, A.
    Consonni, D.
    Vecchi, M.
    Basilisco, G.
    DIGESTIVE AND LIVER DISEASE, 2021, 53 : S119 - S120
  • [47] Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational cohort study
    Goebel, Carl H.
    Heinze, Axel
    Karstedt, Sarah
    Morscheck, Mascha
    Tashiro, Lilian
    Cirkel, Anna
    Hamid, Qutayba
    Halwani, Rabih
    Temsah, Mohamad-Hani
    Ziemann, Malte
    Goerg, Siegfried
    Muente, Thomas
    Goebel, Hartmut
    BRAIN COMMUNICATIONS, 2021, 3 (03)
  • [48] The Risk of Hospitalization and Mortality After Breakthrough SARS-CoV-2 Infection by Vaccine Type: Observational Study of Medical Claims Data
    Kshirsagar, Meghana
    Nasir, Md
    Mukherjee, Sumit
    Becker, Nicholas
    Dodhia, Rahul
    Weeks, William B.
    Ferres, Juan Lavista
    Richardson, Barbra
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2022, 8 (11):
  • [49] Observational Study of Patients Hospitalized With Neurologic Events After SARS-CoV-2 Vaccination, December 2020-June 2021
    Kim, Carla Y.
    Mcneill, Emily N.
    Young, Casey
    King, Fredrick
    Clague, Madison
    Caldwell, Marissa
    Boruah, Abhilasha
    Zucker, Jason
    Thakur, Kiran T.
    NEUROLOGY-CLINICAL PRACTICE, 2023, 13 (04)
  • [50] Dynamic immunogenicity after primary and booster inactivated SARS-CoV-2 vaccination in people living with HIV: A longitudinal observational study
    Lu, Ting
    Chen, Zhiwei
    Cao, Yu
    Ao, Ling
    Li, Zisheng
    Gu, Xiaoyi
    Ren, Xingqian
    Wang, Yixuan
    Zhang, Gaoli
    Xiang, Dejuan
    Chen, Min
    Cai, Dachuan
    Hu, Peng
    Zhang, Dazhi
    Peng, Mingli
    Shi, Xiaofeng
    Ren, Hong
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (04)